Department of Integrative Biology and Pharmacology, The University of Texas Health Science Center, Houston, TX 77030.
Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390.
Mol Biol Cell. 2021 Oct 1;32(20):ar3. doi: 10.1091/mbc.E21-05-0251. Epub 2021 Jul 28.
Accumulating evidence indicates that increased ribosome biogenesis is a hallmark of cancer. It is well established that inhibition of any steps of ribosome biogenesis induces nucleolar stress characterized by p53 activation and subsequent cell cycle arrest and/or cell death. However, cells derived from solid tumors have demonstrated different degrees of sensitivity to ribosome biogenesis inhibition, where cytostatic effects rather than apoptosis are observed. The reason for this is not clear, and the p53-specific transcriptional program induced after nucleolar stress has not been previously investigated. Here we demonstrate that blocking rRNA synthesis by depletion of essential rRNA processing factors such as LAS1L, PELP1, and NOP2 or by inhibition of RNA Pol I with the specific small molecule inhibitor CX-5461, mainly induce cell cycle arrest accompanied by autophagy in solid tumor-derived cell lines. Using gene expression analysis, we find that p53 orchestrates a transcriptional program involved in promoting metabolic remodeling and autophagy to help cells survive under nucleolar stress. Importantly, our study demonstrates that blocking autophagy significantly sensitizes cancer cells to RNA Pol I inhibition by CX-5461, suggesting that interfering with autophagy should be considered a strategy to heighten the responsiveness of ribosome biogenesis-targeted therapies in p53-positive tumors.
越来越多的证据表明,核糖体生物发生的增加是癌症的一个标志。已经证实,抑制核糖体生物发生的任何步骤都会诱导核仁应激,其特征是 p53 激活,随后细胞周期停滞和/或细胞死亡。然而,来自实体瘤的细胞对核糖体生物发生抑制表现出不同程度的敏感性,观察到的是细胞生长抑制而非细胞凋亡。其原因尚不清楚,核仁应激后诱导的 p53 特异性转录程序也尚未被研究过。在这里,我们证明通过耗尽必需的 rRNA 加工因子(如 LAS1L、PELP1 和 NOP2)或用特异性小分子抑制剂 CX-5461 抑制 RNA Pol I 来阻断 rRNA 合成,主要会诱导固体肿瘤衍生细胞系中的细胞周期停滞伴随自噬。通过基因表达分析,我们发现 p53 协调了一个涉及促进代谢重塑和自噬的转录程序,以帮助细胞在核仁应激下存活。重要的是,我们的研究表明,阻断自噬会显著增强癌症细胞对 CX-5461 抑制 RNA Pol I 的敏感性,这表明干扰自噬应该被认为是提高针对核糖体生物发生的治疗方法在 p53 阳性肿瘤中的反应性的一种策略。